prepared as
follows. One milligram of the peptide was hydrated with 40 μL
of 0.2 M NaOH solution, and subsequently, phosphate buffered saline
(PBS, 140 mM NaCl, 13 mM Na2HPO4, and 2.5 mM
NaH2PO4, pH 7.4) was added in 200 μL portions
up to 1 mL. After each step, the peptide dispersion was sonicated
in a water bath sonicator (Fisher Scientific, Loughborough, UK) for
3 min at 30 °C. Before reaching to final volume, the pH was adjusted
to pH 7.4 by dropwise adding 0.2 M HCl. To prepare the OVA-SA peptide
formulation, one milligram of this peptide was dissolved in 200 μL
of HFIP. After solvent evaporation, the obtained peptide film was
hydrated in 40 μL of 0.2 M NaOH, and then similar to other peptide
preparations, 1 mL of PBS (140 mM NaCl, 13 mM Na2HPO4, and 2.5 mM NaH2PO4, pH 7.4) was added
in 200 μL portions. After pH adjustment, some of the peptide
formulations were supplemented with CpG (20 μg per injection;
10 μL of a 2 mg/mL of a stock solution of CpG in PBS) as an
adjuvant (